Advent Life Sciences

Advent Life Sciences

London, Englandadventls.com

Overview

Advent Life Sciences is a venture capital firm dedicated to investing in life sciences businesses . Focusing on innovative companies in biotechnology, pharmaceuticals, medical devices, and diagnostics, Advent Life Sciences supports the development of breakthrough technologies and therapies . By providing capital and strategic expertise, the firm helps entrepreneurs navigate the complexities of the life sciences sector, accelerating the path from research to market . Advent Life Sciences is committed to advancing healthcare solutions that improve patient outcomes and address unmet medical needs globally . They invest in early and mid-stage companies with a first-in-class or best-in-class approach . Their investments are focused on new drug discovery, including small molecules, biologics, and new modalities, as well as med tech, enabling technologies, and vaccines .

Year Founded

2006

Portfolio Companies

25

Investments

CompanyDateStageLead
Beacon TherapeuticsJan 2026Series CCo-investor
Cyted HealthAug 2025Series BLead
GlycomineApr 2025Series CLead
EpitopeaOct 2024Pre SeedCo-investor
EpitopOct 2024VC RoundCo-investor

Key People

Raj Parekh

General Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year Founded2006

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.